How many employees work at Alchemab Therapeutics?
Alchemab Therapeutics Ltd. has approximately 81 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Alchemab Therapeutics’s total headcount has grown 9.9% from 74 employees in 2023 to 81 in 2026.
Is Alchemab Therapeutics hiring right now?
No, Alchemab Therapeutics is not actively hiring. Alchemab Therapeutics had 0 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About Alchemab Therapeutics’s Workforce
Alchemab Therapeutics Ltd. is a Biotech and Healthcare Services company that employs 81 people worldwide as of March 2026. It is the 7th-largest by headcount among its peers. Founded in 2019, the company is headquartered in London, United Kingdom.
Alchemab Therapeutics's workforce has grown 9.9% from 2023 to 2026, up 8.1% year over year in 2026. It fell to a low of 57 in 2025 Q2 before recovering. Its workforce is concentrated most in Northern Europe (100.0%).
Alchemab Therapeutics's functional groups are Engineering (49.8%), Finance and Operations (33.7%), and Sales and Marketing (16.5%), with Finance and Operations growing fastest (up 30.4%). The average salary is $100,339, highest in Northern Europe at a median of $78,000, down 2.8% year over year in 2026.
Alchemab Therapeutics's hiring activity held steady in 2026.
Sourced from Revelio Labs workforce data.
- Headquarters
- London, United Kingdom
- Founded
- 2019
- Industry
- Biotech and Healthcare Services
- Employees
- 81
- YoY
- +8.1% (+23)
As of March 2026
Alchemab Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Alchemab Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsAlchemab Therapeutics Annual Employee Count (2023-2026)
- Alchemab Therapeutics had 81 employees in 2026, a 8.1% increase (+23) from 2025.
- Alchemab Therapeutics had 71 employees in 2025, a 2.0% decline (+14) from 2024.
- Alchemab Therapeutics had 57 employees in 2024, a 6.8% decline (-11) from 2023.
- Alchemab Therapeutics had 68 employees in 2023, a 3.0% decline (-3) from 2022.
Alchemab Therapeutics's total workforce has grown from 74 employees in 2023 to 81 in 2026.
Alchemab Therapeutics Ltd. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 81 | +23 | +8.1% |
| 2025 | Q4 | 71 | +14 | -2.0% |
| 2025 | Q3 | 67 | +5 | -8.7% |
| 2025 | Q2 | 57 | -10 | -13.1% |
| 2025 | Q1 | 58 | -11 | -6.8% |
| 2024 | Q4 | 57 | -11 | -6.8% |
| 2024 | Q3 | 62 | -6 | +0.1% |
| 2024 | Q2 | 67 | -7 | -7.0% |
| 2024 | Q1 | 69 | +0 | -3.0% |
| 2023 | Q4 | 68 | -3 | -3.0% |
| 2023 | Q3 | 68 | -2 | -2.4% |
| 2023 | Q2 | 74 | +0 | +6.8% |
See Alchemab Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataAlchemab Therapeutics Employee Count by Region (2026)
Northern Europe accounts for the largest share of Alchemab Therapeutics's global workforce with approximately 100% of total employees.
Alchemab Therapeutics employees by region
| Region | Employees | % of Total |
|---|---|---|
| Northern Europe | 81 | 100.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataAlchemab Therapeutics Employee Count by Department (2026)
Alchemab Therapeutics's employee groups are Engineering (49.8%), Finance and Operations (33.7%), and Sales and Marketing (16.5%).
Alchemab Therapeutics employees by department
| Department | Employees | % of Total |
|---|---|---|
| Engineering | 41 | 49.8% |
| Finance and Operations | 27 | 33.7% |
| Sales and Marketing | 13 | 16.5% |
Compare Alchemab Therapeutics's department mix to industry peers.
See Full DataAlchemab Therapeutics Employee Salary by Region (2026)
Alchemab Therapeutics's average employee salary is $100,339 globally. Employees in Northern Europe receive the highest compensation.
Alchemab Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Northern Europe | $78,000 |
Unlock salary by role, level, and city — and compare to Alchemab Therapeutics's industry peers.
Unlock Salary DataAlchemab Therapeutics Job Openings and Hiring Trends (2023-2026)
- Alchemab Therapeutics had 0 active job postings in 2026, a 0% no change (-2) from 2025.
- Alchemab Therapeutics had 2 active job postings in 2025, a 200.0% increase (+2) from 2024.
- Alchemab Therapeutics had 0 active job postings in 2024, a 0% no change from 2023.
- Alchemab Therapeutics had 0 active job postings in 2023, a 200.0% decline from 2022.
- Hiring velocity in 2026: 0 new roles/month, down from 1 in 2025 and 0 in 2024.
Alchemab Therapeutics's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About Alchemab Therapeutics
- How fast is Alchemab Therapeutics growing?
- In 2026, Alchemab Therapeutics's headcount grew 8.1% to 81 employees, up from 58 in 2025.
- See the full headcount history
- Where are Alchemab Therapeutics employees located?
- Most Alchemab Therapeutics employees are based in Northern Europe (100.0% of headcount).
- Explore where the workforce is based
- What is the average salary at Alchemab Therapeutics?
- The average employee salary at Alchemab Therapeutics is approximately $100.3k per year.
- Analyze the salary distribution
- How many new job postings does Alchemab Therapeutics open per year?
- In Q1 2026, Alchemab Therapeutics opened 0 new job postings. In 2025, Alchemab Therapeutics opened 13 new job postings — about 1 per month.
- Track hiring trends by role
- When was Alchemab Therapeutics founded and where is it headquartered?
- Alchemab Therapeutics was founded in 2019 and is headquartered in London, United Kingdom.
- Compare Alchemab Therapeutics to industry peers
Speak with a workforce expert about Alchemab Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.